SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-048361
Filing Date
2017-09-15
Accepted
2017-09-15 21:45:56
Documents
1
Period of Report
2017-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 v475327_4.html 4  
1 FORM 4 v475327_4.xml 4 4213
  Complete submission text file 0001144204-17-048361.txt   5653
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258
Business Address
ZELDIS JEROME B (Reporting) CIK: 0001433982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 171088881